---
title: 'Medicine ğŸŠâ­'
date: 2023-01-03
permalink: /other/medicine
tags:
  - other
toc: true
---

Essences of clinical medicine.

{% include toc %}

# Cardiology / å¾ªç’°å™¨ç§‘

# Pulmonology/ å‘¼å¸å™¨ç§‘

# Gastroenterology / æ¶ˆåŒ–å™¨ç§‘

# Endocrinology / å†…åˆ†æ³Œç§‘

# Nephrology / è…è‡“ç§‘

# Hematology / è¡€æ¶²ç§‘

# Rheumatology / ãƒªã‚¦ãƒãƒç§‘

# Infectious Diseases / æ„ŸæŸ“ç—‡ç§‘

# Neurology / ç¥çµŒç§‘

# Psychiatry / ç²¾ç¥ç§‘

# Ophthalmology / çœ¼ç§‘

# Otolaryngology / è€³é¼»å’½å–‰ç§‘

# Dermatology / çš®è†šç§‘

## Pigmentation Disease / è‰²ç´ ç–¾æ‚£

### Freckle / é›€åµæ–‘

* **Overview**
  * Enhanced pigment production/transfer of melanocytes
* **Subjective**
  * Small brown macules on face
  * Darken/Fade in summer/winter: Degree of pigmentation depends on sunlight
* **Assessment**
  * Suspect neurofibromatosis if >=6 larger macules (cafe-au-lait spot)
{: .notice--info}

### Lentigo / é»’å­

* **Overview**
  * Benign localized hyperplasia of melanocytes
* **Subjective**
  * Oval tan-brown macule/patch
* **Objective**
  * [Pathology] Linear melanocytic hyperplasia above basement membrane
{: .notice--info}

### Melanocytic Nevus / è‰²ç´ æ€§æ¯æ–‘

* **Overview**
  * Benign neoplasm of melanocytes
  * Mostly due to activating mutation in RAS signaling pathway
* **Subjective**
  * Tan to brown, uniformly pigmented, well-defined small macules
* **Objective**
  * [Pathology] Nests or cords of nevus cells: Progress from dermoepidermal junction (junctional) to dermis (compound) and loss in epidermis (intradermal)
* **Assessment**
  * [Variant] Congenital nevus: Large variants have increased melanoma risk
  * [Variant] Blue nevus: Black-blue nodule
  * [Variant] Spitz nevus: Red-pink nodule
  * [Variant] Halo nevus: Immune response against nevus cells
  * [Variant] Dysplastic nevus: Potential marker or precursor of melanoma
  * [Related] Nevus of Ota: Blue discoloration in periorbital region
  * [Related] Mongolian spot: Blue discoloration in lumbosacral region from birth
{: .notice--info}

### Melanoma / æ‚ªæ€§é»’è‰²è…«

* **Overview**
  * Malignant neoplasm of melanocytes, related to UV light
  * Driver mutations in CDKN2A, RAF/RAS, TERT promoter
* **Subjective**
  * Macules characterized by "ABCDE": Asymmetry, Border irregularity, Color variegation, Diameter enlargement, Evolution
* **Objective**
  * [Dermoscopy] Parallel ridge pattern, atypical pigment network: Extensive melanocyte proliferation
  * [Pathology] Nests of atypical cells with enlarged nuclei, prominent nucleoli, increased mitosis: Initial radial growth, later vertical growth
* **Assessment**
  * [Type] Acral lentiginous melanoma: Unrelated to sun exposure, most common in Asian/Africa
  * [Type] Superficial spreading melanoma: Related to sun exposure, most common in Western world
  * [Type] Nodular melanoma: Vertical growth
  * [Type] Lentigo maligna melanoma: indolent growth over decades
  * [Staging] T: By tumor thickness
* **Plan**
  * Surgical resection, sentinel lymph node biopsy, lymph node dissection: Before metastasis
  * [Immune checkpoint inhibitor] Anti-CTLA4, anti-PD1: Melanoma is inherently immunogenic
  * [Target therapy] BRAF inhibitor, MEK inhibitor: Inhibit RAS signaling pathway
{: .notice--info}

### Vitiligo Vulgaris / å°‹å¸¸æ€§ç™½æ–‘

* **Overview**
  * Pigment loss due to melanocyte loss, may be due to autoimmune melanocyte destruction or nerve innervation abnormality
* **Subjective**
  * Well-demarcated zone of pigment loss
* **Assessment**
  * [Type] Segmental: Following dermatome
  * [Type] Non-segmental: Not following dermatome
* **Plan**
  * Topical steroid
  * UVB
{: .notice--info}

## Benign Epithelial Tumor / è‰¯æ€§ä¸Šçš®è…«ç˜

### Seborrheic Keratosis / è„‚æ¼æ€§è§’åŒ–ç—‡

* **Overview**
  * Benign proliferation of keratinocytes (basal cell, squamous cell)
  * Frequent in middle-aged or older individuals
  * Often due to activating mutation in FGFR3
* **Subjective**
  * Well-demarcated, tan to dark brown plaque with granular surface
* **Objective**
  * [Pathology] Basaloid cells with melanin pigmentation, keratin-filled cyst (horn cyst)
* **Assessment**
  * Suspect gastrointestinal malignancy if suddenly appear in large numbers (Leser-Trelat sign)
{: .notice--info}

### Acanthosis Nigricans / é»’è‰²è¡¨çš®è…«

* **Overview**
  * Hyperplasia of keratinocytes
  * Causes include inheritance, obesity, diabetes, malignancy (especially gastrointestinal)
  * Often due to FGFR3 mutation (familial), IGF1R activation (diabetes), EGFR activation (malignancy)
* **Subjective**
  * Thickened hyperpigmented rough skin in flexural areas
* **Objective**
  * [Pathology] Papillomatosis, hyperkeratosis, hyperpigmentation
{: .notice--info}

### Fibroepithelial Polyp / è»Ÿæ€§ç·šç¶­è…«

* **Overview**
  * Benign skin hyperplasia (skin tag)
* **Subjective**
  * Soft and flesh-colored tumor, often with stalk
* **Objective**
  * [Pathology] Fibrovascular core covered by benign epithelium
{: .notice--info}

### Epithelial Cyst / è¡¨çš®å›Šè…«

* **Overview**
  * Invagination and cystic expansion of epidermis or hair follicle
* **Subjective**
  * Skin-colored, dome-shaped nodule
  * Painful if inflammed
* **Objective**
  * [Pathology] Keratin-filled cyst with epidermal wall
{: .notice--info}

### Appendage Tumor / ä»˜å±å™¨è…«ç˜

* **Overview**
  * Neoplasm arising from or differentiating toward skin appendage, mostly benign
* **Objective**
  * [Pathology] Pilomatrixoma: Resembling germinal portion of hair bulb
  * [Pathology] Trichoepithelioma: Resembling primitive hair follicle
  * [Pathology] Syringoma, eccrine poroma: Resembling eccrine gland
  * [Pathology] Apocrine carcinoma: Resembling apocrine gland
  * [Pathology] Cylindroma: Resembling eccrine/apocrine duct
  * [Pathology] Sebaceous adenoma: Resembling sebaceous gland
{: .notice--info}

## Malignant Epithelial Tumor / æ‚ªæ€§ä¸Šçš®è…«ç˜

### Actinic Keratosis / æ—¥å…‰è§’åŒ–ç—‡

* **Overview**
  * Precancerous neoplasm of keratinocytes due to UV light, may progress to SCC
* **Subjective**
  * Tan-brown or red macule with scale or horn
* **Objective**
  * [Pathology] Hyperplasia of atypical basal cell, parakeratosis, elastosis
* **Plan**
  * Surgical resection, freezing
  * Topical imiquimod: Activate TLR and innate immune response
{: .notice--info}

### Extramammary Paget Disease / ä¹³æˆ¿å¤–Pagetç—…

* **Overview**
  * Malignant neoplasm of Paget cell within epidermis (intraepidermal adenocarcinoma)
* **Subjective**
  * Large erythematous (and erosive) patch on external genitalia
* **Objective**
  * [Pathology] Large cell with clear cytoplasm within epidermis: Paget cell
* **Plan**
  * Wide excision
{: .notice--info}

### Squamous Cell Carcinoma / æœ‰æ£˜ç´°èƒç™Œ

* **Overview**
  * Malignant neoplasm of keratinocytes due to UV light (other causes: immunosuppression, chronic ulcer, burn scar)
  * Mutation in TP53, and RAS and NOTCH signaling pathway
* **Subjective**
  * Red nodule/plaque with scale and/or ulceration
* **Objective**
  * [Pathology] Atypical cells with variable differentiation, involve full-thickness epidermis and invade dermis
* **Assessment**
  * [Variant] Keratoacanthoma: Dome-shaped tumor with central keratinous plug, well-differentiated SCC that often spontaneously regress
* **Plan**
  * Surgical resection, radiotherapy
{: .notice--info}

### Basal Cell Carcinoma / åŸºåº•ç´°èƒç™Œ

* **Overview**
  * Malignant neoplasm of basaloid cell, related to UV light
  * Locally aggressive but slow growing and rarely metastasize
  * Due to mutation in Hedgehog signaling pathway (often PTCH)
* **Subjective**
  * Brown to black pearly papules/nodules, sometimes with ulcer
* **Objective**
  * [Dermoscopy] Telangiectasias, multifocal or nodular growth
  * [Pathology] Nests of basaloid cells, peripheral palisading, artificial cleft
* **Plan**
  * Surgical resection
{: .notice--info}

## Dermal Tumor / çœŸçš®è…«ç˜

### Dermatofibroma / çš®è†šç·šç¶­è…«

* **Overview**
  * Benign neoplasm of fibroblast and histiocyte
* **Subjective**
  * Tan to brown firm papule/nodule
* **Objective**
  * [Pathology] Benign spindle cells in dermis, overlying epidermal hyperplasia
{: .notice--info}

### Dermatofibrosarcoma Protuberans / éš†èµ·æ€§çš®è†šç·šç¶­è‚‰è…«

* **Overview**
  * Malignant neoplasm of fibroblast
  * Locally aggressive but slow growing and rarely metastasize
  * Due to COL1A1-PDGFB translocation, lead to increased PDGFÎ² secretion
* **Subjective**
  * Firm protuberant nodule
* **Objective**
  * [Pathology] Storiform fibroblast, often extend to subcutaneous fat
* **Plan**
  * Surgical resection
{: .notice--info}

### Mycosis Fungoides / èŒçŠ¶æ¯è‚‰ç—‡

* **Overview**
  * Malignant neoplasm of CD4+ T-helper cells involving skin (cutaneous T cell lymphoma)
  * Localized to skin initially, may evolve to systemic lymphoma after years
* **Subjective**
  * Multiple erythematous patches: Erythematous stage
  * Red to brown scaling plaques: Plaque stage
  * Brown ulcerated nodule: Tumor stage
* **Objective**
  * [Pathology] CD4+ lymphocyte infiltration, band-like in dermis, Pautrier microabscess in epidermis
* **Plan**
  * Topical steroid, UV light: For early stage
  * Systemic chemotherapy: For advanced stage
{: .notice--info}

### Mastocytosis / è‚¥æº€ç´°èƒç—‡

* **Overview**
  * Benign proliferation of mast cells in skin (urticaria pigmentosa)
  * Due to mutation in KIT (and also PDGFRA)
* **Subjective**
  * Multiple red-brown patches/nodules, mainly in children
  * Localized edema when lesion rubbed (Darier sign): Histamine release from mast cells
  * Wheals, pruritus, flush triggered by food or temperature change: Histamine release from mast cells
* **Objective**
  * [Pathology] Proliferation of mast cells in dermis
* **Assessment**
  * Spontaneous resolve in children
{: .notice--info}


## Vascular Tumor / è¡€ç®¡è…«ç˜

### Vascular Ectasia / è¡€ç®¡æ‹¡å¼µç—‡

* **Overview**
  * Dilatations of capillaries/venules/arterioles, not neoplasm
* **Subjective**
  * [Nevus flammeus] Pink/purple patch on head/neck in infant, regress spontaneously (except port wine stain which persists)
  * [Spider telangiectasia] Radial pulsatile lesion, associated with hyper-estrogenic state
* **Assessment**
  * [Association] Sturge-Weber syndrome: Vascular ectasia of face (port wine stain), leptomenings (intellectual disability, hemiplegia), choroid plexus (glaucoma), due to GNAS mutation
  * [Association] Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): Multiple telangiectasias on skin/mucosa, causing recurrent epistaxis
{: .notice--info}

### Hemangioma / è¡€ç®¡è…«

* **Overview**
  * Benign neoplasm of endothelial cell with blood-filled vessels
* **Subjective**
  * Blood-rich tumor on skin/mucosa or viscera
* **Assessment**
  * [Capillary hemangioma] Common, with thin-walled capillaries
  * [Cavernous hemangioma] Infiltrative, with cavernous vascular space, associated with von Hippel-Lindau disease
  * [Juvenile hemangioma] Common in newborn, mostly regress
  * [Pyogenic granuloma] Rapidly growing pedunculated lesion, easily bleeding
{: .notice--info}

### Lymphangioma / ãƒªãƒ³ãƒ‘ç®¡è…«

* **Overview**
  * Benign neoplasm of lymphatic endothelial cell
* **Subjective**
  * Tumor on head/neck/axilla
* **Assessment**
  * [Capillary lymphangioma] 
  * [Cavernous lymphangioma] Associated with Turner syndrome
{: .notice--info}

### Glomus Tumor / ã‚°ãƒ­ãƒ ã‚¹è…«ç˜

* **Overview**
  * Benign neoplasm of smooth muscle cell of glomus body
* **Subjective**
  * Painful tumor on distal digit (often under fingernails)
{: .notice--info}

### Bacillary Angiomatosis / ç´°èŒæ€§è¡€ç®¡è…«ç—‡

* **Overview**
  * Vascular proliferation in immunocompromised hosts due to Bartonella infection (produce HIF and induce vascular proliferation
* **Subjective**
  * Red papules/nodules
{: .notice--info}

### Kaposi Sarcoma / Kaposiè‚‰è…«

* **Overview**
  * Borderline neoplasm of endothelial cell, caused by HHV8 infection and immunosuppression (AIDS, transplant, aging)
  * HHV8 infect endothelial cell and stimulate growth
* **Subjective**
  * Red-purple patches â†’ plaques â†’ nodules
* **Objective**
  * [Pathology] Irregular vascular space, plump spindle cells, interspersed erythrocytes and mononuclear cells
  * [PCR] HHV8 (+)
* **Assessment**
  * [Type] Classic KS: In older man, not HIV-related
  * [Type] Endemic African KS: In younger African, not HIV-related
  * [Type] Transplant-associated KS: In organ transplant recipient under immunosuppression
  * [Type] AIDS-associated KS: Most common, AIDS-defining illness
* **Plan**
  * Surgery, radiotherapy, chemotherapy
  * Withdrawal of immunosuppression: Transplant-associated
  * Antiretroviral therapy: AIDS-associated
{: .notice--info}

### Angiosarcoma / è¡€ç®¡è‚‰è…«

* **Overview**
  * Malignant neoplasm of endothelial cell, idiopathic or related to lymphedema after mastectomy, radiation, trauma
* **Subjective**
  * Initial red papules, later red-tan nodules with blurring margin, bleeding and ulceration: Often in head/neck of elderly
* **Objective**
  * [Pathology] Irregular vascular space, atypical endothelial cells (various degree of differentiation)
* **Plan**
  * Surgery, radiotherapy, chemotherapy
{: .notice--info}

## Acute Inflammatory Dermatosis / æ€¥æ€§ç‚ç—‡æ€§çš®è†šç–¾æ‚£

### Urticaria / ã˜ã‚“ã¾ç–¹

* **Overview**
  * Dermal microvascular hyperpermeability due to localized mast cell degranulation of histamine
  * Causes include antigens, exercise, temperature change, stress
* **Subjective**
  * Pruritic edematous plaques (wheals)
  * Develop and fade within hours, episode for days to months
* **Objective**
  * [Pathology] Edema and dilated vessels in superficial dermis
* **Assessment**
  * [Related] Angioedema: Edema of deeper dermis and subcutaneous fat
  * [Related] C1 inhibitor deficiency: Hereditary angioedema due to excessive bradykinin production
* **Plan**
  * Antihistamine
  * Avoid causative agents
{: .notice--info}

### Acute Eczematous Dermatitis / æ€¥æ€§æ¹¿ç–¹æ€§çš®è†šç‚

* **Overview**
  * Acute inflammatory dermatosis, often due to immune reaction mediated by CD4+ T lymphocytes
  * Causes include external antigen (plant, metal), internal antigen (food, drug), predisposition (atopy)
* **Subjective**
  * Erythematous pruritic patch/plaque, sometimes with papules/vesicles/crusts/scales: Acute phase
  * Lichenification, pigmentation: Chronic phase
  * [Contact dermatitis] Lesion coincides with contact region
  * [Atopic dermatitis] Recurrent and chronic course, symmetrical distribution
* **Objective**
  * [Pathology] Spongiosis (epidermal edema), acanthosis, hyperkeratosis, inflammatory cell infiltration
  * [Contact dermatitis] Patch test positive
  * [Atopic dermatitis] IgEâ†‘, eosinophilâ†‘
* **Assessment**
  * [Clinical] Contact dermatitis: Due to contact of causative agents (allergic/irritant)
  * [Clinical] Atopic dermatitis: Due to atopy and impaired skin barrier function
* **Plan**
  * Topical steroid
  * [Contact dermatitis] Avoid causative agents
  * [Atopic dermatitis] Tacrolimus ointment (calcineurin inhibitor): Inhibit cytokine release from T cells
  * [Atopic dermatitis] JAK inhibitor: Inhibit signal transduction in immune cells
{: .notice--info}

### Erythema Multiforme / å¤šå½¢ç´…æ–‘

* **Overview**
  * Hypersensitivity reaction of skin, due to keratinocyte injury mediated by CD8+ T lymphocytes
  * Causes include infection (herpes, mycoplasma), drug (sulfonamide, carbamazepine), cancer, collagen disease
* **Subjective**
  * Multiple target-like erythematous macules/plaques
  * [SJS] Extensive erythema with blister/erosion on skin/mucosa, febrile
  * [TEN] Extensive erythema with necrosis/sloughing of skin/mucosa (burn-like), febrile
* **Objective**
  * [Pathology] Keratinocyte necrosis, lymphocyte infiltrates along dermoepidermal junction
  * [Patho, SJS] Keratinocyte necrosis in cluster
  * [Patho, TEN] Keratinocyte necrosis in layer
* **Assessment**
  * [Variant] Stevens-Johnson syndrome: Involvement < 10% BSA
  * [Variant] Toxic epidermal necrolysis: Involvement > 10% BSA
  * [Variant] Drug-induced hypersensitivity syndrome: With liver dysfunction, anti-HHV6 antibodyâ†‘
* **Plan**
  * Topical steroid, antihistamine
  * [SJS, TEN] Terminate causative drug, systemic steroid
{: .notice--info}

### Acute Febrile Neutrophilic Dermatosis / æ€¥æ€§ç†±æ€§å¥½ä¸­çƒæ€§çš®è†šç—‡

* **Overview**
  * Tender erythematous nodule with fever, related to hematologic or solid malignancy
  * Also called Sweetâ€™s disease
* **Subjective**
  * Tender erythematous nodule/plaque, on face/upper-limbs
  * Often with high fever, arthralgia
* **Objective**
  * [Pathology] Neutrophilic infiltration in dermis, edema of dermal papilla
  * [Blood] Neutrophilâ†‘, CRPâ†‘
* **Plan**
  * NSAID, corticosteroid
{: .notice--info}

### Pyoderma Gangrenosum / å£Šç–½æ€§è†¿çš®ç—‡

* **Overview**
  * Noninfectious necrotic ulcer, related to systemic disease (inflammatory bowel disease, hematologic malignancy, rheumatoid arthritis)
* **Subjective**
  * Necrotic ulcer with violaceous elevated edge
* **Objective**
  * [Pathology] Neutrophilic infiltration in dermis
{: .notice--info}

## Chronic Inflammatory Dermatosis / æ…¢æ€§ç‚ç—‡æ€§çš®è†šç–¾æ‚£

### Seborrheic Dermatitis / è„‚æ¼æ€§çš®è†šç‚

* **Overview**
  * Chronic inflammatory dermatosis involving regions with high density of sebaceous glands
  * Causes related to sebum production and Malassezia colonization
* **Subjective**
  * Erythematous greasy macules/patches with scales and crusts
* **Objective**
  * [Pathology] Spongiosis, acanthosis, parakeratosis at hair follicle ostia
* **Plan**
  * Antifungal shampoo
  * Corticosteroid cream
{: .notice--info}

### Psoriasis / ä¹¾ç™¬

* **Overview**
  * Chronic inflammatory dermatosis with autoimmune basis (environmental + genetic)
  * Result from T cell infiltration, cytokine secretion, keratinocyte proliferation
* **Subjective**
  * Multiple well-demarcated salmon-colored plaques with silver-white scale, often on elbow/knee/scalp
  * [Koebner phenomenon] New lesion induced by local trauma: Local inflammation becomes self-perpetuating
  * [Auspitz sign] Pinpoint bleeding when scales scraped off: Thinning of epidermis overlying dermal papillae
  * [Nail change] Pitting, onycholysis
  * [Psoriatic arthritis] Pain, deformity, associated with HLA-B27
* **Objective**
  * [Pathology] Acanthosis, elongated rete ridges, hyperkeratosis, parakeratosis: Increased keratinocyte turnover rate
  * [Pathology] Neutrophil aggregate in superficial epidermis (spongiform pustule) and stratum corneum (Munro microabscess): Local inflammation
* **Assessment**
  * [Type] Psoriasis vulgaris (most common): Erythematous plaques with white scale
  * [Type] Guttate psoriasis: Multiple small drop-shaped lesions
  * [Type] Pustular psoriasis: Localized or generalized lesions with pustules; including palmoplantar pustulosis
  * [Type] Palmoplantar pustulosis: Pustules on palms and soles, related to metal allergy and smoking; associated with sternocostoclavicular hyperostosis
  * [Type] Psoriatic erythroderma: Generalized erythroderma and scaling
* **Plan**
  * Topical therapy: Steroid, vitamin D
  * Light therapy: PUVA, UVB
  * Biological agents: Anti-TNFÎ±, anti-IL17, anti-IL23
{: .notice--info}

### Lichen Planus / æ‰å¹³è‹”ç™¬

* **Overview**
  * Chronic inflammatory dermatosis
  * May be due to CD8+ T cells response elicited by altered antigen expressed in basal cell
* **Subjective**
  * Multiple pruritic purple papule/plaque with white lines on skin/mucosa
  * [Wickham striae] White lines in lace-like pattern: Hypergranulosis
  * [Koebner phenomenon] New lesion induced by local trauma: Local inflammation becomes self-perpetuating
* **Objective**
  * [Pathology] Band-like lymphocytes infiltrate along dermoepidermal junction: Interface dermatitis
  * [Pathology] Basal keratinocyte degeneration and squamatization, dermoepidermal interface sawtoothing: Destruction of basal cells
  * [Pathology] Acanthosis, hypergranulosis, hyperkeratosis: Chronic changes
* **Plan**
  * Topical steroid
{: .notice--info}

## Blistering Disease / æ°´ç–±æ€§ç–¾æ‚£

### Pemphigus / å¤©ç–±ç˜¡

* **Overview**
  * Blistering disease due to autoantibody against protein for adherence between keratinocytes (desmoglein)
* **Subjective**
  * Multiple flaccid bullae, rupture/erosion/erythema, in skin/mucosa: Dissolution of epidermis/epithelium
* **Objective**
  * [Pathology] Acantholysis in deep epidermis (suprabasal blister), row of tombstones: In pemphigus vulgaris/vegetans, anti-Dsg3 (deep)
  * [Pathology] Acantholysis in superficial epidermis (subcorneal blister): In pemphigus foliaceus/erythematosus, anti-Dsg1 (superficial)
  * [Pathology] Net-like IgG deposit (all-layer for vulgaris, superficial for foliaceus): Autoantibody against desmoglein (component of desmosome)
  * [Serology] Anti-Dsg3 IgG (+) (vulgaris), anti-Dsg1 IgG (+) (foliaceus)
* **Assessment**
  * [Type] Pemphigus vulgaris (most common): Suprabasal blister, anti-Dsg3
  * [Type] Pemphigus vegetans: Vegetating plaques, anti-Dsg3
  * [Type] Pemphigus foliaceus (second common): Subcorneal blister, anti-Dsg1
  * [Type] Pemphigus erythematosus: Lupus-like erythema, anti-Dsg1
  * [Type] Paraneoplastic pemphigus: Often non-Hodgkin lymphoma
* **Plan**
  * Steroid, immunosuppressant
{: .notice--info}

### Bullous Pemphigoid / æ°´ç–±æ€§é¡å¤©ç–±ç˜¡

* **Overview**
  * Blistering disease due to autoantibody against protein for adherence of basal keratinocytes to basement membrane (BPAG2)
* **Subjective**
  * Multiple tense bullae, pruritic erythema, in skin/mucosa: Detachment of epidermis and dermis
* **Objective**
  * [Pathology] Separation of basal keratinocytes and basement membrane (subepidermal blister), lymphocyte and eosinophil infiltrate: Due to anti-BPAG2
  * [Pathology] Linear IgG deposit at dermoepidermal junction: Autoantibody against BPAG2 (component of hemidesmosome)
  * [Serology] Anti-BPAG2 IgG (+)
* **Plan**
  * Topical steroid
  * Tetracycline
{: .notice--info}

### Dermatitis Herpetiformis / ç–±ç–¹çŠ¶çš®è†šç‚

* **Overview**
  * Blistering disease due to antibody cross-reacting with protein for anchoring of basement membrane to dermis (reticulin)
* **Subjective**
  * Pruritic grouped vesicles and erythema (urticaria)
* **Objective**
  * [Pathology] Separation of basement membrane and superficial dermis (subepidermal blister), neutrophil infiltrate at tip of dermal papillae
  * [Pathology] Granular IgA deposit at dermal papillae: Autoantibody against reticulin (anchoring fiber of basement membrane)
* **Assessment**
  * Often associated with celiac disease: IgA antibody cross-react to reticulin
* **Plan**
  * Topical steroid
  * Gluten-free diet: If associated with celiac disease
{: .notice--info}

### Epidermolysis Bullosa / è¡¨çš®æ°´ç–±ç—‡

* **Overview**
  * Blistering disease due to inherited defect in structural protein of skin
* **Assessment**
  * [Type] Simplex: Blister in basal cell layer, due to mutation of keratin 14/5
  * [Type] Junctional: Blister in lamina lucida, due to mutation of laminin
  * [Type] Dystrophic: Blister beneath lamina densa, due to mutation of COL7A1
{: .notice--info}

### Porphyria / ãƒãƒ«ãƒ•ã‚£ãƒªãƒ³ç—‡

* **Overview**
  * Congenital (or acquired) disturbances of porphyrin metabolism
* **Subjective**
  * Urticaria and vesicles, exacerbated by sun exposure
* **Objective**
  * [Pathology] Subepidermal blister, abnormal vessel at superficial dermis
* **Assessment**
  * [Type] Congenital erythropoietic porphyria
  * [Type] Erythropoietic protoporphyria
  * [Type] Acute intermittent porphyria
  * [Type] Porphyria cutanea tarda
{: .notice--info}

## Skin Appendage Disease / çš®è†šä»˜å±å™¨ç–¾æ‚£

### Acne Vulgaris / å°‹å¸¸æ€§ç—¤ç˜¡

* **Overview**
  * Inflammation of hair follicle and sebaceous gland
  * Contributed to keratin plug blocking sebum outflow, androgen inducing sebaceous gland hypertrophy, Propionibacterium acnes resulting in proinflammatory fatty acids
* **Subjective**
  * Erythematous papule/nodule/pustule, with/without central black keratin plug: Open/closed comedones
* **Objective**
  * [Pathology] Open or closed comedones, immune cell infiltrate
* **Plan**
  * Antibiotics: For Propionibacterium acnes
  * Vitamin A derivative: Inhibit sebum production
{: .notice--info}

### Rosacea / é…’çš¶

* **Overview**
  * Chronic inflammation around hair follicle, related to innate immune response
* **Subjective**
  * Persistent erythema/telangiectasia, papules/pustules, rhinophyma (nasal skin thickening)
* **Objective**
  * [Pathology] Perifollicular lymphocyte infiltrate, dermal edema and telangiectasia
{: .notice--info}

## Panniculitis / è„‚è‚ªç¹”ç‚

### Erythema Nodosum / çµç¯€æ€§ç´…æ–‘

* **Overview**
  * Inflammation of subcutaneous fat septa, related to delayed hypersensitivity reaction
  * Causes include infection, drug, sarcoidosis, IBD, malignancy
* **Subjective**
  * Poorly-defined erythematous tender patch/nodule
* **Objective**
  * [Pathology] Edema, fibrin exudation, and infiltration of subcutaneous fat septa
{: .notice--info}

### Erythema Induratum / ç¡¬çµæ€§ç´…æ–‘

* **Overview**
  * Inflammation of subcutaneous fat lobule, related to vasculitis
  * Vasculitis of deep vessels supplying subcutaneous fat leads to fat necrosis
* **Subjective**
  * Erythematous slightly-tender nodule, often ulcerated: In lower extremity
* **Objective**
  * [Pathology] Granulomatous inflammation and caseous necrosis of subcutaneous fat lobule
{: .notice--info}

## Infectious Disease / æ„ŸæŸ“ç—‡

### Herpes Simplex / å˜ç´”ç–±ç–¹

* **Overview**
  * Viral infection caused by herpes simplex virus (HSV1/HSV2), primary or latent infection
  * Latent infection in trigeminal ganglion (HSV1) or sacral ganglion (HSV2), reactivated in immunocompromised state (stress)
* **Subjective**
  * [Labial] Painful vesicles on lips and perioral region
  * [Genital] Painful vesicles on external genitalia, symmetric ulceration
* **Assessment**
  * [Variant] Herpetic gingivostomatitis: Oral mucosa involvement in children
  * [Variant] Kaposiâ€™s varicella form eruption: Widespread involvement in patient with weakened skin barrier (atopic dermatitis)
  * [Variant] Herpetic whitlow: Finger involvement in infant
* **Objective**
  * [Pathology] Intraepithelial vesicles
  * [Cytology] Giant cell, inclusion body
* **Plan**
  * Anti-herpes drugs: Acyclovir and derivatives
{: .notice--info}

### Herpes Zoster / å¸¯çŠ¶ç–±ç–¹

* **Overview**
  * Viral infection caused by varicella-zoster virus (VZV), latent infection (primary: chickenpox)
  * Latent infection in dorsal root ganglia, reactivated in immunocompromised state (aging, stress, malignancy, HIV, steroid)
* **Subjective**
  * Vesicles with erythema along dermatome (unilateral, band-like)
  * Neuropathic pain, may cause persistent neuralgia
* **Assessment**
  * [Variant] Ramsay Hunt syndrome: Facial palsy due to involvement of CN VII geniculate ganglion
* **Plan**
  * Anti-herpes drug: Acyclovir and derivatives
  * NSAID: For acute pain
  * Pregabalin: For post-herpetic neuralgia
{: .notice--info}

### Verruca / ç–£è´…

* **Overview**
  * Viral infection caused by human papillomavirus (HPV), transmitted by direct contact
  * HPV 16/18 are carcinogenic due to E6 inhibiting p53
* **Subjective**
  * [Verruca vulgaris] Tan papules/nodules on various location
  * [Verruca plana] Slightly elevated papules on face/dorsal-hand
  * [Verruca plantaris] Ant-hill-like nodules on soles/palms
  * [Condyloma acuminata] Cauliflower-like mass on genitalia/anus
* **Objective**
  * [Pathology] Papillomatous epidermal hyperplasia, cytoplasmic vacuolization (koilocytosis)
* **Assessment**
  * [Type] Verruca vulgaris: HPV 2/27/57
  * [Type] Verruca plana: HPV 3/10
  * [Type] Condyloma acuminatum: HPV 6/11
* **Plan**
  * [Verruca vulgaris] Topical salicylic acid, cryotherapy,
  * [Condyloma acuminatum] Topical imiquimod, cryotherapy
{: .notice--info}

### Molluscum Contagiosum / ä¼æŸ“æ€§è»Ÿå±è…«

* **Overview**
  * Viral infection caused by a poxvirus, transmitted by direct contact
* **Subjective**
  * Multiple skin-colored umbilicated papules, curd-like material from central umbilication
* **Objective**
  * [Pathology] Cup-like epidermal hyperplasia, molluscum body (large cytoplasmic inclusion) in stratum granulosum/corneum
{: .notice--info}


### Impetigo / è†¿ç—‚ç–¹

* **Overview**
  * Superficial bacterial infection caused by staphylococcus/streptococcus, highly contagious
  * Local invasion result in serous exudate (crust), exfoliative toxin cleave desmoglein 1 (blister)
* **Subjective**
  * Erythematous macule/patch with honey-colored crust (contagiosa) or blister/erosion (bullosa)
* **Objective**
  * [Pathology] Neutrophil accumulation beneath stratum corneum
* **Assessment**
  * [Type] Impetigo contagiosa: Caused by Î²-hemolytic streptococcus (also S. aureus now)
  * [Type] Impetigo bullosa: Caused by Staphylococcus aureus
  * [Variant] Staphylococcal Scalded Skin Syndrome: Extensive shallow burn-like desquamation in infants due to release of staphylococcal exfoliative toxin into bloodstream
{: .notice--info}

### Tinea / ç™½ç™¬

* **Overview**
  * Superficial fungal infection caused by dermatophytes (mainly Trichophyton)
* **Subjective**
  * [Tinea capitis] Scalp, erythematous patch with hair loss
  * [Tinea corporis] Various location, expanding round erythematous patch
  * [Tinea cruris] Inguinal area, erythematous patch with scaly border
  * [Tinea pedis] Sole, diffuse erythema and scaling (interdigital, vesicular, hyperkeratotic)
  * [Tinea unguium] Nail, discoloration and thickening and deformity
  * [Tinea versicolor] Trunk, discolored macule or patch, caused by Malassezia furfur instead of dermatophyte
* **Objective**
  * [Pathology] Red hyphae in stratum corneum under PAS stain
  * [KOH] Septate hyphae
* **Plan**
  * Topical azoles/allylamines
{: .notice--info}

### Scabies / ç–¥ç™¬

* **Overview**
  * Itchy skin rash caused by Sarcoptes scabiei parasitizing corneum layer, transmitted by direct or indirect contact
* **Subjective**
  * Extremely pruritic red papules
  * Track-like burrows (scabies burrow)
* **Plan**
  * Topical phenothrin, oral ivermectin
{: .notice--info}


# Orthopedic Surgery / æ•´å½¢å¤–ç§‘

# Urology / æ³Œå°¿å™¨ç§‘

# Gynecology / å©¦äººç§‘

## Vulva Disorder / å¤–é™°ç–¾æ‚£

### Bartholin Cyst / Bartholinè…ºåš¢èƒ

* **Overview**
  * Infection of Bartholin gland due to obstruction of duct
* **Subjective**
  * Cyst, pain
* **Plan**
  * Excision, marsupialization
{: .notice--info}

### Lichen Sclerosus / ç¡¬åŒ–æ€§è‹”ç™¬

* **Overview**
  * Chronic skin lesion, related to autoimmune
* **Subjective**
  * Smooth white patch/plaque, mostly on genitalia
* **Objective**
  * [Pathology] Thinning of epidermis, sclerosis of superficial dermis, bandlike lymphocyte infiltrate in dermis
{: .notice--info}

### Lichen Simplex Chronicus / æ…¢æ€§å˜ç´”æ€§è‹”ç™¬

* **Overview**
  * Chronic skin lesion, related to rubbing/scratching (squamous cell hyperplasia)
* **Subjective**
  * Thickened scaly plaque
* **Objective**
  * [Pathology] Acanthosis, hyperkeratosis
{: .notice--info}

### Vulvar Intraepithelial Neoplasia & Carcinoma / å¤–é™°ä¸Šçš®å†…è…«ç˜ãƒ»ç™Œ

* **Overview**
  * Premalignant and malignant neoplasm of vulvar epithelium, related or unrelated to high-risk HPV (16/18)
* **Subjective**
  * Gray-while papule/plaque: Vulvar intraepithelial neoplasia
  * Exophytic or ulcerated lesion: Vulvar carcinoma
* **Objective**
  * [Pathology] Immature basaloid cells within epidermis: Classic vulvar intraepithelial neoplasia
  * [Pathology] Immature basaloid cells invading dermis: Basaloid carcinoma
  * [Pathology] Atypical but mature basal/squamous cells within epidermis: Differentiated vulvar intraepithelial neoplasia
  * [Pathology] Atypical but mature keratinizing squamous cells invading dermis: Keratinizing squamous cell carcinoma
* **Assessment**
  * [Type, HPV] Classic vulvar intraepithelial neoplasia: Due to HPV infection
  * [Type, HPV] Basaloid and warty carcinoma: From classic VIN, younger age
  * [Type, non-HPV] Differentiated vulvar intraepithelial neoplasia: Due to long-standing lichen sclerosus or lichen simplex chronicus
  * [Type, non-HPV] Keratinizing squamous cell carcinoma: From differentiated VIN, older age
* **Plan**
  * Excision, vulvectomy
{: .notice--info}

### Papillary Hidradenoma / ä¹³é ­çŠ¶æ±—è…ºè…«

* **Overview**
  * Benign neoplasm of modified apocrine sweat gland
* **Subjective**
  * Subcutaneous nodules on labia majora or interlabial fold
* **Objective**
  * [Pathology] Papillary projections, columnar secretary cells and myoepithelial cells
{: .notice--info}

### Extramammary Paget Disease / ä¹³æˆ¿å¤–Pagetç—…

* **Overview**
  * Malignant neoplasm of modified apocrine sweat gland within epidermis
* **Subjective**
  * Pruritic red patch on labia majora
* **Objective**
  * [Pathology] Large cells with pale cytoplasm (mucopolysaccharide), cytokeratin 7 (+)
* **Plan**
  * Wide excision
{: .notice--info}

## Vagina Disorder / è…Ÿç–¾æ‚£

### Vaginal Adenosis / è…Ÿè…ºç—‡

* **Overview**
  * Residual glandular epithelium in vagina, related to DES exposure in utero
* **Objective**
  * [Pathology] Columnar mutinous epithelium
* **Assessment**
  * [Association] Clear cell carcinoma
{: .notice--info}

### Gartner Duct Cyst / Gartnerç®¡åš¢èƒ

* **Overview**
  * Benign cyst from residual Wolffian duct
* **Subjective**
  * Fluid-filled submucosal cysts in vagina lateral wall
* **Assessment**
  * [Related] MÃ¼llerian cyst: Mucus cyst from mÃ¼llerian duct
{: .notice--info}

### Vaginal Intraepithelial Neoplasia & Carcinoma / è†£ä¸Šçš®å†…è…«ç˜ãƒ»ç™Œ

* **Overview**
  * Premalignant or malignant neoplasm of vagina, due to high-risk HPV (16/18) infection
* **Subjective**
  * Vaginal bleeding
{: .notice--info}

### Embryonal Rhabdomyosarcoma / èƒå…å‹æ¨ªç´‹ç­‹è‚‰è…«

* **Overview**
  * Malignant neoplasm of embryonal rhabdomyoblast (sarcoma botryoides)
* **Subjective**
  * Polypoid grapelike mass in vagina of infants/children
* **Objective**
  * [Pathology] Small round to spindle cells, crowded (superficial) or in edematous stroma (deep)
* **Plan**
  * Surgery + chemotherapy
{: .notice--info}

## Cervix Disorder / å­å®®é ¸ç–¾æ‚£

### Cervicitis / å­å®®é ¸ç®¡ç‚

* **Overview**
  * Acute or chronic inflammation of cervix, due to vaginal environment change (reduced lactobacilli) or infection
  * Environment change: Bleeding, sexual intercourse, vaginal douching, antibiotics
  * Infection: Gonococci, chlamydiae, HSV
* **Assessment**
  * [Type] Acute cervicitis
  * [Type] Chronic cervicitis
{: .notice--info}

### Endocervical Polyp / å­å®®é ¸ç®¡ãƒãƒªãƒ¼ãƒ—

* **Overview**
  * Benign exophytic growth in endocervical canal
* **Subjective**
  * Sessile or polypoid mass in endocervical canal
* **Objective**
  * [Pathology] Fibrous stroma covered by mucus-secreting glands
* **Plan**
  * Curettage
{: .notice--info}

### Cervical Intraepithelial Neoplasia & Carcinoma / å­å®®é ¸éƒ¨ä¸Šçš®å†…è…«ç˜ãƒ»ç™Œ

* **Overview**
  * Premalignant and malignant neoplasm of cervical epithelium, due to high risk HPV (16/18) infection
  * HPV Infect immature squamous cells at squamocolumnar junction
  * HPV replicate in mature squamous cell and establish persistent infection
  * E6 inactivate p53 and and E7 inactivates RB
  * Viral DNA integrates into host cell genome
* **Subjective**
  * Abnormal vaginal bleeding
* **Objective**
  * [Pap smear] Enlarged nuclei (N/C ratioâ†‘), koilocytosis, HPV-DNA (+)
  * [Colposcopy] Aceto-white area
  * [Pathology] Nuclear atypia (enlargement, hyperchromasia, pleomorphism), koilocytic atypia (perinuclear halo)
  * [Pathology] HPV-DNA (upper), Ki-67 (basal>upper), p16 (whole)
  * [Pathology, LSIL] Nuclear atypia in lower 1/3 epithelium
  * [Pathology, HSIL] Nuclear atypia in lower 2/3 to full epithelium
  * [Pathology, squamous] Nests of malignant squamous cells invading stroma
  * [Pathology, adeno] Glandular epithelium with large hyperchromatic nuclei invading stroma
* **Assessment**
  * [Type] LSIL (CIN I): 60% regress, 30% persist, 10% to HSIL
  * [Type] HSIL (CIN II/III): 30% regress, 60% persist, 10% to carcinoma 
  * [Type] Squamous cell carcinoma: 80%
  * [Type] Adenocarcinoma: 15%
  * [Type] Adenosquamous carcinoma: <5%
  * [Type] Neuroendocrine carcinoma: <5%
  * [Stage] Stage 0: Carcinoma in situ
  * [Stage] Stage I: Carcinoma confined to cervix
  * [Stage] Stage II: Carcinoma beyond cervix
  * [Stage] Stage III: Carcinoma to lower 1/3 vagina or pelvic wall
  * [Stage] Stage IV: Carcinoma to bladder/rectum mucosa, beyond true pelvis, metastasis
* **Plan**
  * Observation: LSIL
  * Conization: HSIL
  * Hysterectomy, lymph node dissection: Cancer
  * Radiotherapy, chemotherapy: Advanced
  * [Prevention] HPV vaccine
{: .notice--info}

## Uterus Disorder / å­å®®ç–¾æ‚£

### Uterine Anomaly / å­å®®å¥‡å½¢

* **Overview**
  * Abnormal uterus development from Mullerian duct
* **Subjective**
  * Infertility, recurrent pregnancy loss
  * Menstrual molimen
* **Objective**
   * [Hysterosalpingography] Uterine anomaly
* **Assessment**
  * [Type] Unicornuate uterus
  * [Type] Double uterus
  * [Type] Bicornuate uterus
  * [Type] Septate uterus
  * [Type] Arcuate uterus
  * [Type] Imperforate hymen
* **Plan**
  * Hysteroplasty
{: .notice--info}

### Dysfunctional Uterine Bleeding / æ©Ÿèƒ½æ€§å­å®®å‡ºè¡€

* **Overview**
  * Abnormal/absent uterine bleeding due to hormonal disturbances
  * [DUB] Causes include puberty, perimenopausal, weight loss, stress, hyperprolactinemia, PCOS
  * [Amenorrhea] Causes include anorexia nervosa, Sheehan syndrome, premature ovarian failure, Turner syndrome
* **Subjective**
  * Polymenorrhea, oligomenorrhea, menorrhagia, hypomenorrhea
  * Amenorrhea
  * Infertility
* **Objective**
  * [Pathology] Stromal condensation without secretory changes (subnuclear vacuoles, predecidual changes)
* **Assessment**
  * [Condition] Anovulatory cycle: Failure of ovulation causes excessive estrogen stimulation unopposed by progesterone
  * [Condition] Luteal insufficiency: Shortened luteal phase due to insufficient secretion of progesterone
  * [Condition] Amenorrhea: Absent estrogen/progesterone stimulation due to hypothalamus/pituitary/ovary lesion
* **Plan**
  * Progestogen, estrogen-progestogen: For bleeding
  * Clomiphene, gonadotropin: For infertility
{: .notice--info}

### Endometritis / å­å®®å†…è†œç‚

* **Overview**
  * Acute or chronic inflammation of endometrium
* **Subjective**
  * Pelvic pain, abnormal bleeding
* **Assessment**
  * [Type] Acute endometritis: Due to retained conception products after delivery/miscarriage
  * [Type] Chronic endometritis: Due to chronic PID, retained gestational tissue, intrauterine contraceptive devices, tuberculosis
* **Plan**
  * Curettage
  * Antibiotics
{: .notice--info}

### Endometriosis / å­å®®å†…è†œç—‡

* **Overview**
  * Ectopic endometrial tissue outside of uterus, theories include regurgitation, metastasis, metaplasia, stem cell
  * Common sites: Douglas pouch, ovary, peritoneum
  * Additional alteration: Release of proinflammatory and angiogenic factors, increased estrogen and retinoic acid production, mutation in tumor suppressor genes and oncogenes
* **Subjective**
  * Dysmenorrhea, dyspareunia, pelvic pain: In reproductive female
  * Infertility: Due to adhesion
  * [Adenomyosis] Menometrorrhagia
* **Objective**
  * [Pelvic exam] Retroverted uterus, restricted mobility
  * [Ultrasound, MRI] Ovarian cyst, myometrium thickening (adenomyosis)
  * [Laparoscopy] Red/black/white peritoneum lesion
  * [Blood] CA125â†‘
  * [Pathology, gross] Bleeding, fibrous adhesions, chocolate cyst
  * [Pathology, micro] Endometrial gland and stroma, atypical features (cytologic atypia, glandular crowding) 
* **Assessment**
  * [Related] Adenomyosis: Endometrial tissue in myometrium
  * [Association] Ovarian cancer (endometriosis, clear cell)
* **Plan**
  * Hormone: LEP, progestin, GNRH agonist, danazol
  * Surgery: Ablation, excision, adhesiolysis, hysterectomy
{: .notice--info}

### Endometrial Polyp / å­å®®å†…è†œãƒãƒªãƒ¼ãƒ—

* **Overview**
  * Benign exophytic growth of endometrium, responsive to estrogen (related to tamoxifen)
* **Subjective**
  * Sessile or polypoid mass
{: .notice--info}

### Endometrial Hyperplasia / å­å®®å†…è†œå¢—æ®–ç—‡

* **Overview**
  * Benign or premalignant proliferation of endometrial gland, due to prolonged estrogen stimulation of endometrium
  * Causes: Prolonged estrogen administration, obesity, PCOS, granulosa cell tumor
  * Often with PTEN inactivating mutation (same as endometrial carcinoma)
* **Subjective**
  * Abnormal vaginal bleeding
* **Objective**
  * [Ultrasound] Endometrium thickening
  * [Pathology] Increased gland-to-stroma ratio, retained intervening stroma: Typical hyperplasia
  * [Pathology] Nuclear atypia (vesicular nuclei, prominent nucleoli), back-to-back gland crowding: Atypical hyperplasia
* **Assessment**
  * [Type] Typical hyperplasia: Rarely progress to carcinoma
  * [Type] Atypical hyperplasia: Often progress to carcinoma
* **Plan**
  * Observation: Typical hyperplasia
  * Hysterectomy: Atypical hyperplasia
  * Curettage + progestin: Atypical hyperplasia but desire birth
{: .notice--info}

### Endometrial Carcinoma / å­å®®å†…è†œç™Œ

* **Overview**
  * Malignant neoplasm of endometrial gland
  * Type I: Due to unopposed estrogen (obesity, nulliparity, PCOS), mutations include PTEN, PIK3CA, KRAS, ARID1A, also MSI, POLE, TP53
  * Type II: Due to endometrial atrophy, mutations include TP53, also chromosomal instability
  * MMMT: Due to sarcomatous transformation, mutations include PTEN, TP53, PIK3CA, 
* **Subjective**
  * Abnormal vaginal bleeding: Irregular, postmenopausal
  * Hypogastric pain
* **Objective**
  * [Hysteroscopy] Exophytic mass, atypical vessels
  * [Ultrasound] Endometrium thickening
  * [MRI] Junctional zone defect
  * [Pathology, endometrioid] Well-formed glands, solid sheets: Well-differentiated (gland only), moderately-differentiated (solid <50%), poorly differentiated (solid >50%)
  * [Pathology, serous] Papillary growth, cytologic atypia
  * [Pathology, carcinosarcoma] Mixed epithelial and stromal components (metastasis only epithelial)
* **Assessment**
  * [Type] Type I (endometrioid): More, younger, better prognosis
  * [Type] Type II (serous): Less, older, poorer prognosis
  * [Type] MMMT (carcinosarcoma): Least, similar to type II
  * [Grade] Grade 1~3: Endometrioid
  * [Grade] Grade 3: Serous
  * [Stage] Stage I: Carcinoma confined to corpus uteri
  * [Stage] Stage II: Carcinoma to cervix
  * [Stage] Stage III: Carcinoma to outside of uterus
  * [Stage] Stage IV: Carcinoma to bladder/rectum mucosa, beyond true pelvis, metastasis
* **Plan**
  * Hysterectomy
  * Adjuvant radiotherapy/chemotherapy
{: .notice--info}

### Adenosarcoma / è…ºè‚‰è…«

* **Overview**
  * Neoplasm with malignant endometrial stroma and benign endometrial gland
* **Objective**
  * [Pathology] Biphasic pattern of malignant stroma and benign glands
{: .notice--info}

### Stromal Tumor / é–“è³ªæ€§è…«ç˜

* **Overview**
  * Benign or malignant neoplasm of endometrial stroma, often due to translocation including JAZF1-SUZ12, YWHAE-NUTM2A/B
* **Assessment**
  * [Type] Stromal nodule: Benign
  * [Type] Low-grade stromal sarcoma: JAZF1-SUZ12 fusion
  * [Type] High-grade stromal sarcoma: YWHAE-NUTM2A/B fusion
{: .notice--info}

### Leiomyoma / å­å®®ç­‹è…«

* **Overview**
  * Benign neoplasm of smooth muscle cell, related to estrogen, alteration include HMGIC/HMGIY rearrangement and MED12 mutation
* **Subjective**
  * Abnormal vaginal bleeding, menorrhagia, dysmenorrhea
  * Hypogastric pain, low back pain, frequent urination
  * Infertility, increased spontaneous abortion
* **Objective**
  * [Echo, MRI, hysteroscopy] Solid pelvic mass
  * [Pathology] Circumscribed round firm gray-white tumors: At intramural, submucosal, subserosal
  * [Pathology] Uniform spindle cell, low mitotic index
* **Assessment**
  * Malignant transformation is extremely rare
* **Plan**
  * Observation
  * GnRH agonist
  * Myomectomy, hysterectomy
{: .notice--info}

### Leiomyosarcoma / å¹³æ»‘ç­‹è‚‰è…«

* **Overview**
  * Malignant neoplasm of smooth muscle cell, alteration include complex karyotype and MED12 mutation
* **Objective**
  * [Pathology] Nuclear atypia, mitotic index
* **Plan**
  * Hysterectomy
{: .notice--info}

## Fallopian Tube Disorder / åµç®¡ç–¾æ‚£

### Salpingitis / åµç®¡ç‚

* **Overview**
  * Inflammation of Fallopian tube
* **Assessment**
  * [Type] Suppurative salpingitis: Gonococcus or Chlamydiae infection
  * [Type] Tuberculous salpingitis: Mycobacterium infection
{: .notice--info}

### Paratubal Cyst / å‚åµç®¡åš¢è…«

* **Overview**
  * Benign fluid-filled cyst adjacent to fallopian tube, remnant of mullerian duct
* **Objective**
  * [Pathology] Cyst lined by benign serous epithelium
{: .notice--info}

### Fallopian Tube Carcinoma / åµç®¡ç™Œ

* **Overview**
  * Malignant neoplasm of fallopian tube epithelium
  * May be origin of serous ovarian cancer
{: .notice--info}

## Ovary Disorder / åµå·£ç–¾æ‚£

### Functional Cyst / æ©Ÿèƒ½æ€§åš¢èƒ

* **Overview**
  * Unruptured follicles (or ruptured and immediately sealed)
* **Objective**
  * [Ultrasound] Hypoechoic cyst
  * [Pathology] Fluid-filled cyst lined by granulosa cell
* **Assessment**
  * [Type] Follicle cyst: Spontaneous regress
  * [Type] Luteal cyst: Often in pregnancy
{: .notice--info}

### Epithelial Tumor / ä¸Šçš®æ€§è…«ç˜

* **Overview**
  * Neoplasm from mullerian epithelial cell (ovarian/tubal epithelium, endometriosis)
  * [Serous] Related to nulliparity (increased ovulation) and BRCA1/2 germline mutation, derived from benign/borderline tumor (low-grade, KRAS/BRAF mutation) or inclusion cyst of fallopian epithelium (high-grade or BRCA-related, TP53 mutation, genomic imbalance)
  * [Mucinous] KRAS mutation
  * [Endometrioid] Related to endometriosis, similar to endometrial cancer (PTEN/PIK3CA/ARID1A/KRAS mutation)
  * [Clear cell] Related to endometrioisis, similar to endometrial cancer (PTEN/PIK3CA/ARID1A/KRAS mutation)
* **Subjective**
  * Abdominal distention or pain
  * Urinary symptoms, gastrointestinal symptoms: Tumor compression
  * Ascites: Peritoneal seeding
* **Objective**
  * [Blood] CA125â†‘ (serous, endometrioid, clear cell), CEAâ†‘ (mucinous), CA19-9â†‘ (mucinous)
  * [Ultrasound] Unilocular (serous) or multilocular (mucinous) cyst, irregular wall thickening, papillary solid component
  * [Pathology, Serous]  Columnar epithelium (benign), increased complexity (borderline), micropapillary (low-grade), nuclear atypia and stromal invasion (high-grade)
  * [Pathology, Mucinous] Columnar epithelium with mucin (benign), increased complexity (borderline), confluent glandular growth (malignant)
  * [Pathology, Endometrioid] Endometrium-like tubular gland
  * [Pathology, Clear cell] Gestational endometrium-like clear cell, hobnail cell
  * [Pathology, Transitional cell] Urothelium-like nests, ovarian stroma
* **Assessment**
  * [Type] Serous: Benign (60%, cystadenoma/cystadenofibroma), borderline, malignant (low-grade/high-grade), often bilateral
  * [Type] Mucinous: Benign (80%) (cystadenoma/cystadenofibroma), borderline, malignant
  * [Type] Endometrioid: Benign, borderline, malignant (mostly)
  * [Type] Clear cell: Benign, borderline, malignant (mostly)
  * [Type] Transitional cell (Brenner): Benign (mostly), borderline, malignant
  * [Stage] Stage I: Carcinoma confined to ovary
  * [Stage] Stage II: Carcinoma to pelvic organ
  * [Stage] Stage III: Carcinoma to retroperitoneal lymph node or extrapelvic peritoneum
  * [Stage] Stage IV: Metastasis
* **Plan**
  * Cystectomy: For benign tumor
  * Unilateral salpingo-oophorectomy: For early malignant tumor
  * Bilateral salpingo-oophorectomy + hysterectomy + omentectomy: For malignant tumor (staging and debulking)
  * Neoadjuvant chemotherapy + debulking surgery + adjuvant chemotherapy (paclitaxel + carboplatin): For advanced malignant tumor
  * Prophylactic salpingo-oophorectomy: For germline BRCA1/2 mutation
{: .notice--info}

### Sex Cord-Stromal Tumor / æ€§ç´¢é–“è³ªæ€§è…«ç˜

* **Overview**
  * Neoplasm from stromal cell (derived from sex cord)
  * [Granulosa cell tumor] Granulosa cell differentiation, FOXL2 mutation
  * [Sertoli-Leydig cell tumor] Sertoli or Leydig cell differentiation, DICER1 mutation
  * [Fibroma/Thecoma] Stromal fibroblast or theca cell differentiation
* **Subjective**
  * Abnormal genital bleeding (endometrial hyperplasia/carcinoma), proliferative breast disease: Granulosa cell tumor (adult)
  * Precocious puberty: Granulosa cell tumor (juvenile)
  * Amenorrhea, breast atrophy, hirsutism, clitoris hypertrophy, voice deepening: Sertoli-Leydig cell tumor
  * Pelvic mass/pain, ascites, hydrothorax: Fibroma/Thecoma (Meigs syndrome)
* **Objective**
  * [Blood] Estrogenâ†‘ (granulosa), androgenâ†‘ (Sertoli-Leydig), inhibinâ†‘ (both)
  * [Ultrasound] Solid tumor
  * [Pathology, Granulosa cell tumor] Small cuboidal/polygonal cells in cords/sheets, follicle-like structure (Call-Exner body)
  * [Pathology, Sertoli-Leydig cell tumor] Tubules composed of Sertoli/Leydig cells
  * [Pathology, Fibroma/Thecoma] Well-differentiated fibroblast, scant collagenous stroma
* **Assessment**
  * [Type] Granulosa cell tumor: Malignant (low-grade)
  * [Type] Sertoli-Leydig cell tumor: Malignant (low-grade)
  * [Type] Fibroma/Thecoma: Benign
* **Plan**
  * Unilateral salpingo-oophorectomy
  * Bilateral salpingo-oophorectomy + hysterectomy + omentectomy
{: .notice--info}

### Germ Cell Tumor / èƒšç´°èƒè…«ç˜

* **Overview**
  * Neoplasm from germ cell
  * [Teratoma]  Embryonic differentiation
  * [Yolk sac tumor] Extraembryonic differentiation
  * [Choriocarcinoma] Extraembryonic differentiation
  * [Dysgerminoma] No specific differentiation, KIT mutation
* **Subjective**
  * Abdominal mass/pain
  * Acute pelvic pain: Ovarian torsion (often in teratoma)
* **Objective**
  * [Blood] AFPâ†‘ (yolk sac tumor), hCGâ†‘ (choriocarcinoma), LDHâ†‘ (dysgerminoma)
  * [Ultrasound, CT, MRI] Heterogenous cyst (hair ball, fat, tooth) (teratoma), solid tumor
  * [Pathology, Mature teratoma] Ectoderm (squamous epithelium, hair follicles, sebaceous gland, neural tissue), mesoderm (fat, bone, cartilage, thyroid) 
  * [Pathology, Monodermal teratoma] Mature thyroid tissue (struma ovarii)
  * [Pathology, Immature teratoma] Immature neuroepithelium, ectoderm, mesoderm
  * [Pathology, Yolk sac tumor] Central vessel enveloped by tumor cells (Schiller-Duval body)
  * [Pathology, Choriocarcinoma] Proliferating syncytiotrophoblast and cytotrophoblast
  * [Pathology, Dysgerminoma] Nests of large cells with clear cytoplasm, in fibrous stroma with lymphocyte infiltration 
* **Assessment**
  * [Type] Mature teratoma (dermoid cyst): Benign (rarely transform to SCC), associated with inflammatory limbic encephalitis
  * [Type] Monodermal teratoma: Benign (struma ovarii, carcinoid)
  * [Type] Immature teratoma: Malignant
  * [Type] Yolk sac tumor: Malignant
  * [Type] Choriocarcinoma: Malignant
  * [Type] Dysgerminoma: Malignant (counterpart of testicular seminoma), associated with pseudohermaphroditism
* **Plan**
  * Cystectomy: For teratoma
  * Unilateral salpingo-oophorectomy + adjuvant chemotherapy (bleomycin + etoposide + cisplatin): For malignant tumor
{: .notice--info}

### Metastatic Tumor / è»¢ç§»æ€§è…«ç˜

* **Overview**
  * From uterus, fallopian tube, contralateral ovary, breast, colon, stomach, often bilateral
* **Objective**
  * [Pathology] Mucin-producing signet ring cell (Krukenberg tumor): Often from signet ring gastric cancer
{: .notice--info}

### Polycystic Ovarian Syndrome / å¤šå›Šèƒæ€§åµå·£ç—‡å€™ç¾¤

* **Overview**
  * Endocrine disorder related to excessive androgen production and metabolic disorder
* **Subjective**
  * Menstrual abnormality, chronic anovulation, infertility: Endocrine disturbance
  * Hirsutism, acne, voice deepening: Hyperandrogenism
  * Obesity, diabetes mellitus, premature atherosclerosis: Metabolic disorder
* **Objective**
  * [Blood] LHâ†‘, FSHâ†’, androgenâ†‘, estrogenâ†‘
  * [Ultrasound] Polycystic ovary
* **Assessment**
  * [Related] Stromal hyperthecosis: Proliferated and luteinized stromal cells, similar symptoms with PCOS
* **Plan**
  * Weight loss
  * Progestogen, estrogen-progestogen: For menstrual abnormality
  * Clomiphene, gonadotropin, ovarian drilling: For infertility
{: .notice--info}

### Premature Ovarian Failure / æ—©ç™ºåµå·£ä¸å…¨

* **Overview**
  * Premature loss of ovarian function before 40
* **Subjective**
  * Amenorrhea, infertility
  * [Climacteric] Menstrual irregularity, hot flash, flushing, sweating, depression, irritability, insomnia, joint stiffness
* **Objective**
  * [Blood] Estrogenâ†“, GnRHâ†‘
* **Assessment**
  * [Related] Climacteric disturbance: Functional disorders during menopausal period
* **Plan**
  * Hormone replacement therapy
{: .notice--info}

### Ovarian Hyperstimulation Syndrome / åµå·£éå‰°åˆºæ¿€ç—‡å€™ç¾¤

* **Overview**
  * Ovulation induction therapy (particularly hMG-hCG) lead to multiple follicle ovulation and increased vascular permeability, often in PCOS patients
* **Subjective**
  * Abdominal distension, nausea/vomiting: Ascites
  * Dyspnea: Pleural effusion
  * Oliguria: Hemoconcentration
* **Objective**
  * [Ultrasound] Ovary enlargement with multiple cysts, ascites, pleural effusion
  * [Blood] Hemoconcentration, hypoproteinemia
* **Plan**
  * IV fluid, albumin
  * Dopamine
{: .notice--info}

## Sexually Transmitted Infection / æ€§æ„ŸæŸ“ç—‡

### Genital Herpes / æ€§å™¨ãƒ˜ãƒ«ãƒšã‚¹

* **Overview**
  * Infection of external genitalia caused by HSV2/1 with primary and latent infection
  * Latent in lumbosacral nerve ganglia, reactivate under decreased immune function
* **Subjective**
  * External genitalia pain/vesicles/ulcer (kissing ulcer)
  * Fever, lymphadenopathy
* **Objective**
  * [Cytology] Multinucleated giant cell, intranuclear inclusion body
  * [Smear] Culture (+), antigen (+), PCR (+)
* **Plan**
  * Valacyclovir, acyclovir
{: .notice--info}

### Condyloma Acuminatum / å°–åœ­ã‚³ãƒ³ã‚¸ãƒ­ãƒ¼ãƒ

* **Overview**
  * Infection of external genitalia caused by HPV6/11
* **Subjective**
  * Painless exophytic warts on vulvar/perineal/perianal region (less often vagina/cervix)
* **Objective**
  * [Smear] PCR (+)
  * [Pathology] Papillary exophytic growth, koilocytic atypia (nuclear enlargement, perinuclear halo)
* **Plan**
  * Topical imiquimod, cryotherapy
  * [Prevention] HPV vaccine
{: .notice--info}

### Chlamydial Infection / ã‚¯ãƒ©ãƒŸã‚¸ã‚¢æ„ŸæŸ“ç—‡

* **Overview**
  * Infection of lower/upper genital tract caused by Chlamydia trachomatis
* **Subjective**
  * Asymptomatic
  * Serous vaginal discharge, abnormal bleeding: Cervicitis
  * Infertility, ectopic pregnancy: Pelvic inflammatory disease
* **Objective**
  * [Smear] PCR (+)
* **Plan**
  * Macrolide, fluoroquinolone, tetracycline
{: .notice--info}

### Gonococcal Infection / æ·‹èŒæ„ŸæŸ“ç—‡

* **Overview**
  * Infection of lower/upper genital tract caused by Neisseria gonorrhoeae
* **Subjective**
  * Purulent vaginal discharge, abnormal bleeding: Cervicitis
  * Dysuria, urethral discharge: Urethritis
  * Pelvic pain, adnexal tenderness, fever: Pelvic inflammatory disease
  * Infertility, ectopic pregnancy: Pelvic inflammatory disease
* **Objective**
  * [Smear] PCR (+)
  * [Pathology] Inflammatory exudate with gram-negative diplococci: Cervicitis
  * [Pathology] Dilated tube lumen and edematous tubal plicae (acute), scarring and fusing tubal plicae (chronic): Salpingitis
  * [Pathology] Collection of pus in tube/ovary: Pyosalpinx, tubo-ovarian abscess
* **Plan**
  * IV ceftriaxone
  * Surgery: For tubo-ovarian abscess
{: .notice--info}

### Bacterial Vaginosis / ç´°èŒæ€§è†£ç—‡

* **Overview**
  * Infection of lower genital tract caused by mainly Gardnerella vaginalis
* **Subjective**
  * Green-gray fishy vaginal discharge
  * Premature labor
* **Objective**
  * [Smear] Squamous cells covered with coccobacilli
{: .notice--info}

### Genital Candidiasis / ã‚«ãƒ³ã‚¸ãƒ€å¤–é™°è…Ÿç‚

* **Overview**
  * Infection of lower genital tract caused by Candida, exogenous or endogenous (DM, antibiotics, pregnancy)
* **Subjective**
  * Pruritus, erythema, swelling, curdlike discharge
* **Objective**
  * [KOH] Pseudospores, hyphae
* **Plan**
  * Fluconazole (symptomatic case only)
{: .notice--info}

### Vaginal Trichomoniasis / è…Ÿãƒˆãƒªã‚³ãƒ¢ãƒŠã‚¹ç—‡

* **Overview**
  * Infection of lower genital tract caused by Trichomonas vaginalis
* **Subjective**
  * Pruritus, frothy yellow vaginal discharge, dysuria, dyspareunia
  * Red cervical/vaginal mucosa: Strawberry cervix
* **Objective**
  * [Smear] Flagellated ovoid protozoan
* **Plan**
  * Metronidazole
{: .notice--info}

## Breast Disorder / ä¹³æˆ¿ç–¾æ‚£

### Breast Inflammatory Disorder / ä¹³æˆ¿ç‚ç—‡æ€§ç–¾æ‚£

* **Overview**
  * Inflammation of breast due to various causes
* **Subjective**
  * [Acute mastitis] Breast erythema and pain, fever
  * [Squamous metaplasia] Painful erythematous subaerolar abscess, fistula opening on edge of areola
  * [Duct ectasia] Palpable periareolar mass, white nipple secretion
  * [Fat necrosis] Painless palpable mass
  * [Lymphocytic mastopathy] Palpable mass
* **Objective**
  * [Pathology, squamous metaplasia] Squamous metaplasia of lactiferous duct, keratin plug and duct rupture, chronic granulomatous inflammation
  * [Pathology, duct ectasia] Ectatic duct filled lipid-laden macrophage, periductal inflammation and fibrosis
  * [Pathology, fat necrosis] Chalky-white nodules, necrotic adipose tissue, chronic inflammatory cells
  * [Pathology, lymphocytic mastopathy] Collagenized stroma, atrophic ducts, lymphocytic infiltrate
  * [Pathology, granulomatous mastitis] Lobulocentric granulomatous inflammation
* **Assessment**
  * [Type] Acute mastitis: Acute bacterial infection of breast during breastfeeding, mostly due to staphylococcus aureus
  * [Type] Squamous metaplasia of lactiferous ducts: Metaplasia of lactiferous duct leading to recurrent subareolar abscess, related to smoking
  * [Type] Duct ectasia: Ectasia of lactiferous duct leading to periductal inflammation and fibrosis
  * [Type] Fat necrosis: Fat necrosis of breast, related to trauma or surgery
  * [Type] Lymphocytic mastopathy: Inflammation of lactiferous duct, related to autoimmune disease (type 1 DM, thyroid disease)
  * [Type] Granulomatous mastitis: Granulomatous inflammation of mammary lobules, localized or systemic (GPA, sarcoidosis, TB)
* **Plan**
  * [Acute mastitis] Antibiotics, continue lactation
  * [Squamous metaplasia] Drainage, surgical removal of involved duct
  * [Granulomatous mastitis] Antibiotics, steroid
{: .notice--info}

### Nonproliferative Breast Change / éå¢—æ®–æ€§ä¹³è…ºå¤‰åŒ–

* **Overview**
  * Benign nonproliferative changes in breast ductal/acinar epithelium (fibrocystic change)
* **Subjective**
  * Breast pain/tenderness/swelling: Cyclic change with menstruation
* **Objective**
  * [Ultrasound] Heterogenous echogenicity
  * [Mammograph] Dense breast with cysts
  * [Pathology] Cyst, fibrosis, adenosis, apocrine metaplasia
{: .notice--info}

### Proliferative Breast Disease / å¢—æ®–æ€§ä¹³è…ºç–¾æ‚£

* **Overview**
  * Benign proliferation of breast ductal/acinar epithelium (with or without atypia), increased risk of carcinoma
* **Subjective**
  * Breast mass/induration
  * Nipple discharge (bloody/serous): Intraductal papilloma
  * Gynecomastia: Often in puberty or cirrhosis
* **Objective**
  * [Mammograph] Density, calcification
  * [Pathology, typical] Epithelial hyperplasia, sclerosing adenosis, radial sclerosing lesion, intraductal papilloma
  * [Pathology, atypical] Atypical ductal hyperplasia, atypical lobular hyperplasia: Resembling DCIS/LCIS, partially involved duct/lobule
{: .notice--info}

### Breast Cancer / ä¹³ç™Œ

* **Overview**
  * Malignant neoplasm of breast ductal/acinar epithelium, related to estrogen exposure and genetic inheritance
  * [Somatic] Estrogen-dependent proliferation (luminal), PIK3CA mutation (luminal), HER2 amplification (HER2), TP53 mutation (TNBC)
  * [Germline] BRCA1 (TNBC), BRCA2 (luminal), TP53 (HER2), PTEN, STK11, CDH1, PALPB2, ATM, CHEK2 mutations
  * [Lobular] CDH1 mutation, loss of cohesion
* **Subjective**
  * Palpable mass
  * Nipple retraction/discharge/erosion, dimpling sign
  * Erythematous pruritic eruption with crust: Paget disease due to intra-epidermal spread
  * Orange peel-like skin: Inflammatory carcinoma due to dermal lymphatics involvement
  * Male breast cancer: Often BRCA2 germline mutation
* **Objective**
  * [Ultrasound] Posterior attenuation, irregular border
  * [Mammography] Density, spicula, microcalcification
  * [Pathology, DCIS] Proliferation limited to ducts/lobules, comedo (central necrosis/calcification), cribriform, micropapillary, papillary, Paget disease (clear cell in epidermis)
  * [Pathology, LCIS] Loosely cohesive rounded cells, signet ring cells
  * [Pathology, IDC] Tubules, solid nests, ragged sheets, stromal desmoplasia
  * [Pathology, ILC] Decohesive infiltrating tumor cells without tubules, signet ring cells
  * [Pathology, others] Mucin lake (mucinous), well-formed tubules (tubular), papillae (papillary), abundant cytoplasm (apocrine), intercellular fluid (micropapillary), solid sheets (medullary), spindle cell (metaplastic), eosinophilic material (secretory)
* **Assessment**
  * [Molecular type] Luminal A: ER (+), HER2 (-), low proliferation (Ki67â†“)
  * [Molecular type] Luminal B: ER (+), HER2 (-), high proliferation (Ki67â†‘)
  * [Molecular type] HER2-enriched: HER2 (+)
  * [Molecular type] Basal-like (TNBC): ER (-), HER2 (-)
  * [Histologic type] Ductal carcinoma in situ (DCIS): Intraductal spreading, resembling ducts
  * [Histologic type] Lobular carcinoma in situ (LCIS): Intraductal spreading, resembling lobules
  * [Histologic type] Invasive ductal carcinoma (IDC): Stromal invasion, resembling ducts
  * [Histologic type] Invasive lobular carcinoma (ILC): Stromal invasion, resembling lobules
  * [Histologic type] Lobular/mucinous/tubular/papillary carcinoma (luminal), apocrine/micropapillary carcinoma (HER2), medullary/metaplastic/secretory carcinoma (TNBC)
  * [Prognostic factor] Lymph node metastases, distant metastasis, tumor size, locally advanced disease, lymphovascular invasion, inflammatory carcinoma, molecular subtype
* **Plan**
  * Breast-conserving surgery + radiotherapy: For most cases
  * Modified radical mastectomy (+ reconstruction): For locally advanced cases
  * Axillary lymph node dissection: If sentinel lymph node biopsy (+)
  * Chemotherapy (neoadjuvant/adjuvant): For highly proliferative tumors (luminal/HER2/TNBC)  
  * Hormone therapy (tamoxifen, GnRH agonist, aromatase inhibitor): For ER-positive tumors (luminal/HER2)
  * Target therapy (trastuzumab, lapatinib): For HER2-amplified tumors (HER2)
{: .notice--info}

### Fibroadenoma / ç·šç¶­è…ºè…«

* **Overview**
  * Benign neoplasm of intralobular stroma, due to MED12 mutation
* **Subjective**
  * Well-defined mobile mass
* **Objective**
  * [Ultrasound] Well-defined homogeneous mass
  * [Mammograph] Well-defined shadow
  * [Pathology] Proliferated intralobular stroma, compressed epithelium
{: .notice--info}

### Phyllodes Tumor / è‘‰çŠ¶è…«ç˜

* **Overview**
  * Benign (occasionally malignant) neoplasm of intralobular stroma, due to MED12 mutation (TERT if malignant)
* **Subjective**
  * Rapidly enlarging mass
* **Objective**
  * [Pathology] Proliferated stroma covered by epithelium (leaf-like), variable cellularity and mitotic rate
* **Plan**
  * Surgical excision
{: .notice--info}


# Obstetrics / ç”£ç§‘

## Abnormal Early Pregnancy / å¦Šå¨ åˆæœŸã®ç•°å¸¸

### Spontaneous Abortion / è‡ªç„¶æµç”£

* **Overview**
  * Pregnancy loss before 22 gestational week due to fetal (early) or maternal (late) factors
  * Fetal chromosomal anomaly: Aneuploidy, polypoidy, translocation
  * Uterine physical defect: Leiomyoma, polyp, malformation
  * Maternal systemic disorder: Luteal-phase defect, diabetes, hypertension, APS, coagulopathy
  * Infection: Toxoplasma, Mycoplasma, Listeria
* **Subjective**
  * Few vaginal bleeding, mild abdominal pain, closed cervical os: Threatened miscarriage
  * Vaginal bleeding, labor-like abdominal pain, open cervical os: Progressive miscarriage
* **Objective**
  * [Ultrasound] Gestational sac without embryo/fetus: Missed miscarriage
* **Plan**
  * Tocolytics: For threatened miscarriage
  * Curettage: For progressive/missed miscarriage
{: .notice--info}

### Ectopic Pregnancy / ç•°æ‰€æ€§å¦Šå¨ 

* **Overview**
  * Extrauterine implantation of fertilized egg (mostly fallopian tube, also peritoneum/ovary/cervix)
  * Predisposing: Pelvic inflammatory disease, surgery history, intrauterine contraceptive device, assisted reproductive technology
* **Subjective**
  * Amenorrhea, abdominal pain, vaginal bleeding
  * Acute abdominal pain, hemorrhagic shock: Tubal rupture
* **Objective**
  * [Blood] hCGâ†‘
  * [Ultrasound] Extrauterine gestational sac, intraperitoneal hemorrhage
  * [Pathology] Chorionic villi in fallopian tube
* **Plan**
  * Observation: Monitor hCG change
  * Methotrexate (local, systemic)
  * Salpingostomy, tubal resection
{: .notice--info}

### Hyperemesis Gravidarum / å¦Šå¨ æ‚ªé˜»

* **Overview**
  * Unresolved nausea/vomiting during pregnancy, related to endocrine changes
* **Subjective**
  * Nausea, vomiting: Not resolved after middle pregnancy
  * Weight loss
* **Objective**
  * [Urine] Ketone (+)
* **Plan**
  * Eat small amounts frequently
  * IV fluid with glucose, vitamin B1
{: .notice--info}

## Abnormal Late Pregnancy / å¦Šå¨ å¾ŒæœŸã®ç•°å¸¸

### Placenta Previa / å‰ç½®èƒç›¤

* **Overview**
  * Placenta implants in lower uterus near/over internal os, related to previous cesarean section and intrauterine surgery
* **Subjective**
  * [Pregnancy] Vaginal bleeding
  * [Delivery] Massive hemorrhage
* **Objective**
  * [Ultrasound] Placenta covering internal os
* **Assessment**
  * [Related] Vasa previa: Vessels lie across internal os, cause fetal distress during delivery
* **Plan**
  * Cesarean section
{: .notice--info}

### Placenta Accreta / ç™’ç€èƒç›¤

* **Overview**
  * Placental villi penetrate decidua and invade myometrium, related to placenta previa and previous cesarean section
* **Subjective**
  * Difficult placenta separation, severe postpartum bleeding
* **Objective**
  * [Ultrasound, MRI] Absent sonolucent zone, thinning of myometrium
* **Assessment**
  * [Type] Placenta accreta: Villi attach to myometrium
  * [Type] Placenta increta: Villi invade into myometrium
  * [Type] Placenta percreta: Villi penetrate through myometrium
* **Plan**
  * Hemostasis: Uterotonic agents, compression sutures, arterial ligation, arterial balloon occlusion
  * Hysterectomy: If failed placental separation or hemostasis
{: .notice--info}

### Placental Abruption / å¸¸ä½èƒç›¤æ—©æœŸå‰é›¢

* **Overview**
  * Separation of placenta from uterine wall before delivery, related to HDP, CAM, trauma
* **Subjective**
  * Abdominal pain, board-like uterine wall
  * Hemorrhagic shock, DIC: Severe case
* **Objective**
  * [CTG] Late deceleration
  * [Ultrasound] Retroplacental hematoma
  * [Blood] FDPâ†‘, D-dimerâ†‘
* **Plan**
  * Emergent cesarean section
{: .notice--info}

### Chorioamnionitis / çµ¨æ¯›è†œç¾Šè†œç‚

* **Overview**
  * Ascending infection of chorion-amnion by bacteria
* **Subjective**
  * Fever, tachycardia, uterine tenderness, foul vaginal discharge
  * Preterm delivery: Due to cervical maturation, premature rupture of membrane, premature labor pain
* **Objective**
  * [Vaginal discharge] Lactobacillusâ†“, Bacteroides/Gardnerellaâ†‘, pH>4.5, granulotic elastaseâ†‘
  * [Blood] WBCâ†‘
  * [Pathology] Neutrophilic infiltrate of chorion-amnion, cloudy amniotic fluid
* **Assessment**
  * [Stage] Bacterial vaginosis: Lactobacillus replaced by anaerobics (Bacteroides/Gardnerella)
  * [Stage] Subclinical chorioamnionitis: Vaginal discharge findings
  * [Stage] Clinical chorioamnionitis: Maternal infection symptoms
* **Plan**
  * Tocolytics, corticosteroids: Subclinical chorioamnionitis
  * Labor induction, cesarean section: Clinical chorioamnionitis
{: .notice--info}

### Cervical Insufficiency / é ¸ç®¡ç„¡åŠ›ç—‡

* **Overview**
  * Cervix weakening and dilation in middle pregnancy
* **Subjective**
  * Miscarriage, preterm birth
* **Objective**
  * [Pelvic exam] Cervical effacement
  * [Ultrasound] Cervical shortening, internal os dilation
* **Plan**
  * Cervical cerclage
{: .notice--info}

### Premature Delivery / æ—©ç”£

* **Overview**
  * Birth in gestational week <37, causes include chorioamnionitis, cervical insufficiency, multiple pregnancy
* **Subjective**
  * Regular uterine contraction, vaginal bleeding: Threatened premature delivery
  * Watery vaginal discharge, visible fetal presenting part: Premature rupture of membranes
* **Objective**
  * [Ultrasound] Cervical dilation and shortening: Threatened premature delivery
  * [Vaginal discharge] pH>7, AFP(+), IGFBP-1(+), fFN(+): Premature rupture of membranes
* **Assessment**
  * [Condition] Threatened premature delivery: Labor onset before 37 weeks
  * [Condition] Premature rupture of membranes: Amniotic sac rupture before labor onset
  * [Complication] Intraventricular hemorrhage, retinopathy of prematurity, respiratory distress syndrome, patent ductus arteriosus, hyperbilirubinemia: Due to incomplete development
  * [Complication] Cerebral palsy, sepsis, chronic lung disease, necrotizing enterocolitis: Due to fetal inflammatory response syndrome
* **Plan**
  * Tocolytics, corticosteroids: <34 weeks
  * Labor induction, cesarean section: >34 weeks, or intrauterine infection or fetal distress
{: .notice--info}

### Post-term Pregnancy / éæœŸç”£

* **Overview**
  * Birth in gestational week >41
* **Assessment**
  * [Complication] Non-reassuring fetal status: Due to oligohydramnios
  * [Complication] Meconium aspiration syndrome: Due to meconium staining
  * [Complication] Shoulder dystocia: Due to excessively large infant
* **Plan**
  * Labor induction
{: .notice--info}

## Abnormal Fetal Status / èƒå…ã®ç•°å¸¸

### Twin Pregnancy / åŒèƒå¦Šå¨ 

* **Overview**
  * Fertilization of two ova (dizygotic) or division of one fertilized ovum (monozygotic)
* **Objective**
  * [Ultrasound] Two gestational sac: Dichorionic
  * [Ultrasound] One gestational sac, two embryos: Monochorionic
* **Assessment**
  * [Type] Dichorionic diamnionic: Dizytotic or monozygotic (early division)
  * [Type] Monochorionic diamnionic: Monozygotic (intermediate division)
  * [Type] Monochorionic monoamnionic: Monozygotic (late division)
  * [Complication] Spontaneous abortion, premature delivery, anemia, hypertensive disorders of pregnancy
  * [Complication] Twin-to-twin transfusion syndrome: Shunt between monochorionic twin lead to unbalanced blood flow and heart failure (recipient) or fetal growth restriction (donor)
{: .notice--info}

### Fetal Growth Restriction / èƒå…ç™ºè‚²ä¸å…¨

* **Overview**
  * Small-for-gestational-age fetus (weight <-1.5 SD)
  * [Fetal] Chromosomal abnormality, congenital anomaly, fetal infection
  * [Maternal] Preeclampsia, multiple pregnancy, alcohol, cigarette
  * [Placental] Placental infarction, placenta previa, umbilical vascular anomalies, 
* **Subjective**
  * Symmetric growth restriction: Fetal factor
  * Asymmetric growth restriction (sparing of brain): Placental or maternal factor
{: .notice--info}

### Fetal Hydrops / èƒå…æ°´è…«

* **Overview**
  * Accumulation of fluid in fetus
  * [Immune] Rh(-) mother immunized by previous RH(+) fetus RBC, IgG destruct subsequent RH(+) fetus RBC, hemolytic anemia, cardiac decompensation
  * [Nonimmune] Cardiovascular defect (malformation, arrhythmia), chromosomal anomaly (45X, trisomy), fetal anemia (homozygous Î±-thalassemia, B19 infection)
* **Subjective**
  * Generalized edema (hydrops fetalis)
  * Pleural fluid, peritoneal fluid, postnuchal fluid (cystic hydroma)
  * Jaundice, kernicterus: Immune hydrops
* **Objective**
  * [Ultrasound] MCA peak velocityâ†‘: Compensation for anemia
  * [Blood] Indirect Coombs test (+): Presence of antibody
* **Assessment**
  * [Type] Immune hydrops
  * [Type] Nonimmune hydrops
* **Plan**
  * Intrauterine fetal transfusion: For severe fetal anemia or hydrops
  * Anti-D antibody: For maternal isoimmunization
{: .notice--info}

### Polyhydramnios / ç¾Šæ°´éå¤šç—‡

* **Overview**
  * Excessive amniotic fluid (>800mL)
  * Causes: Idiopathic, gestational diabetes, gastrointestinal atresia (esophageal, duodenal), CNS anomaly (ancephaly, spina bifida)
* **Subjective**
  * [Maternal] Abdominal distension, shortness of breath
* **Objective**
  * [Ultrasound] AFP >8cm, AFI >24cm
{: .notice--info}

### Oligohydramnios / ç¾Šæ°´éå°‘ç—‡

* **Overview**
  * Insufficient amniotic fluid (<100mL)
  * Causes: Premature rupture of membranes, renal agenesis (Potter syndrome)
* **Subjective**
  * [Fetal] Pulmonary hypoplasia, limb deformity
* **Objective**
  * [Ultrasound] AFP <2cm, AFI <5cm
{: .notice--info}

## Complicated Pregnancy / åˆä½µç—‡å¦Šå¨ 

### Gestational Diabetes Mellitus / å¦Šå¨ ç³–å°¿ç—…

* **Overview**
  * Pregnancy complicated with preexisting (pregestational) or newly-onset (gestational) diabetes
  * Due to insulin resistance resulting from hormonal change  (hPL)
* **Subjective**
  * [Fetal] Macrosomnia, hypoglycemia, malformation, stillbirth: At birth
  * [Fetal] Obesity, diabetes: Long term
* **Objective**
  * [Blood] Fasting glucose â‰¥ 92, OGTT 1hr â‰¥ 180, OGTT 2hr â‰¥ 153: Gestational DM
  * [Blood] Fasting glucose â‰¥ 126, OGTT 2hr â‰¥ 200, HbA1c â‰¥ 6.5%: Overt DM in pregnancy
* **Assessment**
  * [Type] Pregestational DM: DM diagnosed before pregnancy
  * [Type] Gestational DM: Elevated glucose during pregnancy
  * [Type] Overt DM in pregnancy: DM diagnosed during pregnancy
  * [Course] Usually resolve after delivery, often develop DM years later
* **Plan**
  * Diet therapy
  * Insulin therapy
{: .notice--info}

### Hypertensive Disorders of Pregnancy / å¦Šå¨ é«˜è¡€åœ§ç—‡å€™ç¾¤

* **Overview**
  * Pregnancy complicated with hypertension with/without organ dysfunction, related to aging and obesity
  * [Mechanism] Abnormal trophoblastic implantation, vascular remodeling failure
  * [Mechanism] Placental hypoxia, release of sFlt1 (antagonize VEGF/PGI2) and endoglin (antagonize TGFÎ²/NO)
  * [Mechanism] Vasoconstriction, hyperpermeability, hypercoagulability
  * [Mechanism] Hypertension, kidney damage (preeclampsia), brain damage (eclampsia), liver damage (HELLP)
* **Subjective**
  * Hypertension, edema, proteinuria: Preeclampsia
  * Headache, visual disturbance, convulsions: Eclampsia
  * Acute abdominal pain, fatigue, nausea: HELLP
  * Fetal growth restriction, non-reassuring fetal status
* **Objective**
  * [Urine] Protein (+), P/C ratioâ†‘: Preeclampsia
  * [MRI] Cerebral edema (posterior reversible encephalopathy syndrome): Eclampsia
  * [Blood] Bilirubin/LDHâ†‘, AST/ALTâ†‘, plateletâ†“: HELLP
  * [Patho, placenta] Decidual vasculopathy, villous infarction, syncytial knots 
  * [Patho, organs] Endothelial swelling, fibrin deposition, intraparenchymal hemorrhage
* **Assessment**
  * [Type] Preeclampsia: Proteinuria
  * [Type] Eclampsia: Convulsion
  * [Type] HELLP syndrome: Hemolysis, elevated liver enzyme, low platelet
  * [Course] Usually resolve after delivery
* **Plan**
  * Delivery: If possible
  * Antihypertensive, MgSO4: Control hypertension/convulsion
  * Airway, oxygen: For convulsion episode
{: .notice--info}

### Transplacental Infection / çµŒèƒç›¤æ„ŸæŸ“

* **Overview**
  * Transplacental infection from mother to fetus by virus/bacteria/parasite
* **Subjective**
  * [Rubella] Cataract, cardiac anomaly (PDA), hearing loss
  * [CMV] Microcephaly, intracranial calcification, hepatosplenomegaly, jaundice, petechiae, hearing loss, chorioretinitis
  * [B19] Hydrops fetalis, spontaneous abortion, stillbirth
  * [Zika] Microcephaly, intracranial calcification, arthrogryposis, ocular abnormality
  * [Treponema] Hepatosplenomegaly, rash, osteochondritis, rhinitis (snuffles), saddle nose, Hutchinson teeth, saber shins
  * [Toxoplasma] Chorioretinitis, hydrocephalus, intracranial calcification, seizure, hepatosplenomegaly
* **Assessment**
  * [Pathogen] Rubella virus
  * [Pathogen] Cytomegalovirus
  * [Pathogen] Parvovirus B19
  * [Pathogen] Zika virus
  * [Pathogen] Treponema pallidum
  * [Pathogen] Toxoplasma gondii
{: .notice--info}

### Intrapartum Infection / ç”£é“æ„ŸæŸ“

* **Overview**
  * Intrapartum infection from mother to fetus by virus/bacteria/fungus
* **Subjective**
  * [HSV] Neonatal herpes, mortality
  * [VZV] Neonatal varicella, mortality
  * [HPV] Laryngeal papilloma
  * [HBV] Carrier, chronic hepatitis
  * [HCV] Carrier, chronic hepatitis
  * [HIV] Carier, AIDS
  * [GBS] Pneumonia, meningitis, sepsis
  * [Gonococcus] Suppurative conjunctivitis
  * [Chlamydia] Conjunctivitis, pneumonitis
  * [Candida] Oral thrush
* **Assessment**
  * [Pathogen] Herpes simplex virus
  * [Pathogen] Varicella-zoster virus
  * [Pathogen] Human papilloma virus (6, 11)
  * [Pathogen] Hepatitis B virus
  * [Pathogen] Hepatitis C virus
  * [Pathogen] Human immunodeficiency virus
  * [Pathogen] Group B streptococcus
  * [Pathogen] Neisseria gonorrhea
  * [Pathogen] Chlamydia trachomatis
  * [Pathogen] Candida albicans
{: .notice--info}

## Abnormal Labor / åˆ†å¨©ã®ç•°å¸¸

### Abnormal Labor Mechanism / åˆ†å¨©æ©Ÿè»¢ã®ç•°å¸¸

* **Overview**
  * Abnormality of uterine contraction, fetal presentation, fetal attitude, fetal rotation, and others
* **Assessment**
  * [Contraction] Weak: Interval >6min, duration <40sec
  * [Contraction] Strong: Interval <1min, duration >120sec
  * [Presentation] Breech: Head up
  * [Presentation] Transverse: Head lateral
  * [Attitude] Vertex: Anterior + posterior fontanelle presenting
  * [Attitude] Bregmatic: Anterior fontanelle presenting
  * [Attitude] Brow: Forehead presenting
  * [Attitude] Face: Eye/nose presenting
  * [Rotation] High sagittal: Sagittal suture in longitudinal axis at high position
  * [Rotation] Deep transverse: Sagittal suture in transverse axis at low position
  * [Rotation] Occiput posterior: Occiput facing posterior direction
  * [Entering] Anterior parietal: Sagittal suture displaced posteriorly 
  * [Entering] Posterior parietal: Sagittal suture displaced anteriorly  
  * [Canal] Cephalopelvic disproportion: Head - pelvis mismatch
  * [Canal] Shoulder dystocia: Shoulder - pubic symphysis mismatch
  * [Umbilical] Forelying: Cord lying below fetus
  * [Umbilical] Prolapse: Cord prolapse out
* **Plan**
  * Cesarean section
  * Labor induction
{: .notice--info}

### Non-Reassuring Fetal Status / èƒå…æ©Ÿèƒ½ä¸å…¨

* **Overview**
  * Abnormality of fetal evaluation results, may indicate fetal hypoxia and acidosis
* **Objective**
  * [CTG] Baseline variability decrease/absence, sinusoidal pattern, bradycardia, late/variable/prolonged deceleration
* **Assessment**
  * [Complication] Hypoxic ischemic encephalopathy (cerebral palsy)
* **Plan**
  * Lateral position
  * Adjust uterotonics, tocolysis agents
  * Oxygen, IV fluids
  * Labor induction: If cervix opened and head descended
  * Cesarean section: Otherwise
{: .notice--info}

### Postpartum Hemorrhage / åˆ†å¨©å¾Œç•°å¸¸å‡ºè¡€

* **Overview**
  * Massive bleeding during/after delivery, due to placental separation, birth canal injury, DIC
* **Subjective**
  * Massive bleeding
  * Pallor, perspiration, cyanosis, hypotension, tachycardia, tachypnea
  * Highly-positioned and soft uterus: Atonic bleeding
  * Sudden severe abdominal pain: Uterine rupture
* **Objective**
  * [Blood] Plateletsâ†“, FDPâ†‘, D-dimerâ†‘: DIC
* **Assessments**
  * [Causes] Atonic bleeding: Poor uterine contraction due to myometrium fatigue or placenta retention
  * [Causes] Perineal laceration: Tears involving skin (1), muscle (2), anal sphincter (3), rectal mucosa (4)
  * [Causes] Cervical laceration: Tears involving cervix
  * [Causes] Uterine rupture: Rupture of uterus due to surgical history or excessive uterotonics
  * [Causes] Uterine inversion: Inversion of uterus
  * [Causes] Placenta accreta: Difficult separation of placenta
  * [Causes] Placental abruption: Lead to DIC due to tissue factor entering
  * [Causes] Amniotic fluid embolism: Lead to DIC due to tissue factor entering
* **Plan**
  * Blood transfusion: RBC, platelets, FFP, antithrombin (if DIC)
  * Non-surgical hemostasis: Astriction (hand, balloon), suture, uterotonics, TAE, arterial balloon catheter
  * Surgical hemostasis: Arterial ligation, compression suture, hysterectomy
  * Shock management: Airway, oxygen, fluid, vasopressor
  * Autologous blood donation: Preventive
{: .notice--info}

### Amniotic Fluid Embolism / ç¾Šæ°´å¡æ “ç—‡

* **Overview**
  * Amniotic fluid entering maternal bloodstream, lead to cardiopulmonary collapse (physical embolism) and DIC (anaphylaxis-like)
* **Subjective**
  * Acute chest pain, dyspnea, shock, respiratory arrest, cardiac arrest: Cardiopulmonary collapse
  * Massive hemorrhage and shock: DIC
* **Objective**
  * [Pathology] Fetal components (mucin, ZnCP-1, STN) in pulmonary artery
* **Plan**
  * CPR, anti-shock therapy, anti-DIC therapy
{: .notice--info}

## Abnormal Puerperium / ç”£è¤¥ã®ç•°å¸¸

### Subinvolution of Uterus / å­å®®å¾©å¤ä¸å…¨

* **Overview**
  * Delayed involution of uterus, often due to retention of placental tissue
* **Subjective**
  * Large soft uterus
  * Persistent lochia rubra
* **Plan**
  * Uterotonic agent, uterine curettage
{: .notice--info}

### Puerperal Fever / ç”£è¤¥ç†±

* **Overview**
  * Postpartum fever, often due to infection of of uterus/pelvis
* **Subjective**
  * Fever: â‰¥ 2 days
  * Lower abdominal pain, foul-smelling lochia
* **Plan**
  * Antibiotics, uterine curettage
{: .notice--info}

### Venous Thromboembolism / é™è„ˆè¡€æ “å¡æ “ç—‡

* **Overview**
  * Venous thromboembolism during/after pregnancy, related to obesity and cesarean section
* **Subjective**
  * [DVT] Pain and swelling in one leg
  * [PTE] Acute chest pain, dyspnea
* **Objective**
  * [Ultrasound, DVT] Deep vein thrombus, absent blood flow
  * [Blood, PTE]  PaO2â†“, PaCO2â†“
  * [CT, PTE] Pulmonary artery thrombus, absent blood flow
* **Assessment**
  * [Condition] Deep vein thrombosis
  * [Condition] Pulmonary thromboembolism
* **Plan**
  * Anticoagulation, thrombolytics
  * Oxygen therapy, catheter embolectory: Pulmonary embolism
  * Early ambulation, elastic stockings: Prevention
{: .notice--info}

## Trophoblastic Disorder / çµ¨æ¯›æ€§ç–¾æ‚£

### Hydatidiform Mole / èƒçŠ¶å¥‡èƒ

* **Overview**
  * Abnormal proliferation of chorionic villi
  * [Complete] Fertilization of empty ovum with one sperm + duplication (or two sperm)
  * [Partial] Fertilization of normal ovum with two sperm
* **Subjective**
  * Abnormal vaginal bleeding, hyperemesis
  * Spontaneous abortion, uterine enlargement
* **Objective**
  * [Blood] hCGâ†‘
  * [Ultrasound] Vesicular pattern, luteal cyst
  * [Pathology] Grapelike mass, villous edema, trophoblastic proliferation
* **Assessment**
  * [Type] Complete mole: 46XX / 46XY, without fetal tissue, higher malignancy risk
  * [Type] Partial mole: 69XXX / 69XXY, with fetal tissue, lower malignancy risk
  * [Type] Invasive mole: Invasion into myometrium
* **Plan**
  * Curettage, monitor hCG
  * Chemotherapy: For invasive mole
{: .notice--info}

### Choriocarcinoma / çµ¨æ¯›ç™Œ

* **Overview**
  * Malignant neoplasm of trophoblastic cells
  * Following complete mole, abortion, normal pregnancy
* **Subjective**
  * Abnormal vaginal bleeding
  * Cough, bloody sputum: Lung metastasis
* **Objective**
  * [Blood] hCGâ†‘
  * [Ultrasound] Hypervascular tumor
  * [Pathology] Proliferating trophoblasts without villi, invading myometrium
* **Assessment**
  * [Related] Placental site trophoblastic tumor: Neoplasm of intermediate trophoblasts, good prognosis
* **Plan**
  * Chemotherapy (etoposide, methotrexate, dactinomycin, cyclophosphamide, vincristine): Good respond
{: .notice--info}


# Pediatrics / å°å…ç§‘

